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Zinc is essential for function ofmitochondria as a cofactor for
several matrix zinc metalloproteins. We demonstrate that a
labile cationic zinc component of low molecular mass exists in
the yeast mitochondrial matrix. This zinc pool is homeostati-
cally regulated in response to the cellular zinc status. This pool
of zinc is functionally important because matrix targeting of a
cytosolic zinc-binding protein reduces the level of labile zinc
and interferes with mitochondrial respiratory function. We
identified a series of proteins that modulate the matrix zinc
pool, one of which is a novel conserved mitochondrial protein
designated Mzm1. Mutantmzm1 cells have reduced total and
labile mitochondrial zinc, and these cells are hypersensitive to
perturbations of the labile pool. In addition,mzm1 cells have a
destabilized cytochrome c reductase (Complex III) without any
effects on Complexes IV or V. Thus, we have established that a
link exists between Complex III integrity and the labile mito-
chondrial zinc pool.
All known mitochondrial zinc-requiring metalloproteins
are synthesized in the cytoplasm and must be imported as
newly synthesized polypeptides into the organelle as with
most resident proteins. Protein import into the mitochon-
dria requires unfolded polypeptides, so folding andmetallation
occur upon import. Thus, a bioavailable pool of Zn(II) must be
maintained within the mitochondria for efficient metallation
reactions. The folding of metalloproteins is dependent on the
availability and the selective insertion of the appropriate metal
ion. Mis-metallation by a non-native metal ion may be delete-
rious yielding either an inactive protein or a misfolded state
prone to aggregation.
The zinc mitochondrial metalloproteome is large relative to
other metals and distributed throughout the organelle (1). The
zinc proteome is heavily populated by proteases and in yeast
include the iAAA, mAAA, Oma1, Oct1, Icp55, Atp23, and the
MPP protease complex. These proteases all share an essential
HEXXH or HXXEH metal-binding motif and whereas many
metalloproteinases can be activated in vitro by diverse divalent
cations, Zn(II) is likely to be the physiological metal ion bound.
Zn(II) is an abundant cofactor for a variety of additional
metalloenzymes in mitochondria, including Adh3, Adh4, and
Leu9 in the matrix, in addition to Cu,Zn Sod1 and Hot13 in the
IMS (2). Last, cytochrome c oxidase requires Zn(II) in its Cox4
subunit (3).
Cellular Zn(II) acquisition in eukaryotes is achieved through
a conserved ZIP (or SLC39) family of transporters (4). ZIP
transporters in yeast (Zrt1 and Zrt2) and mammals predomi-
nately translocate Zn(II) from the extracellular space or
organelles into the cytoplasm. A second class of eukaryotic
Zn(II) transporters is the cation diffusion facilitator (CDF, ZnT,
or SLC30) family that typically translocate Zn(II) from the cyto-
plasm either into organelles or out of the cell (4, 5). Both fami-
lies of transporters are polytopic intrinsic membrane proteins.
Fourteen candidate ZIP and ten distinct ZnT transporters are
known in the human genome, whereas yeast possess five ZIP
and five CDF transporters (6). Zn(II) transporters have been
identified that mediate Zn(II) uptake into the ER, Golgi, and
vacuole compartments (4), although no ZnT or ZIP mitochon-
drial transporters have been identified.
Within eukaryotic cells, labile Zn(II) pools have been identi-
fied using Zn(II)-responsive fluorophores (7, 8). Punctate fluo-
rescent components seen in a myriad of cell types have been
termed zincosomes (9), although the compartment has not
been fully defined (4). Labile Zn(II) pools have been described
in the brain, pancreas, prostate, and the retina. The correlation
of the cellular fluorescence with labile Zn(II) pools is compli-
cated by caveats such as the binding affinity of the fluorophore,
discrimination among diverse metal ions, and a tendency of
fluorophores to compartmentalize. Nonetheless, the visualiza-
tion of labile Zn(II) pools with fluorophores of varying Zn(II)
binding affinities suggests that cells contain pools of kinetically
labile, ligand-bound Zn(II) (9).
One defined labile Zn(II) pool resides in presynaptic boutons
in mossy fiber neurons within the hippocampus (7). These pre-
synaptic vesicles are also enriched with glutamate as a neuro-
transmitter. The vesicles accumulate Zn(II) to 0.3 mM
through the ZnT-3 Zn(II) transporter (10–12). Synaptic cleft
Zn(II) is a modulator of glutamate receptors and post-synaptic
neuronal Zn(II) may have a second messenger effect.
Labile Zn(II) is also seen in secretory granules in pancreatic
cells, mast cells, intestinal paneth cells, and prostate epithelial
cells (8). Ligands stabilizing the labile Zn(II) pools have not
been defined, although the presence of high citrate in prostate
secretory granules and glutamate inmossy fiber neuronal gran-
ules suggest that these compounds may stabilize Zn(II).
Labile Zn(II) pools have also been observed within mito-
chondria. A labile mitochondrial Zn(II) pool distinct from pro-
tein-bound Zn(II) was identified using the mitochondrial-spe-
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cific Zn-responsive fluorophore RhodZin-3 in neuronal cells
(13, 14). The labile pool was shown to be dependent on the IM
membrane potential and to be mobilized upon mitochondrial
depolarization. No information exists on the ligands that stabi-
lize labile Zn(II) in mitochondria nor the effects of zinc status
on this pool.
We describe presently the identification of a labile Zn(II)
pool within yeast mitochondria that is responsive to the exog-
enous Zn(II) level. High throughput screens were conducted to
identify proteins important for the maintenance of the mito-
chondrial labile Zn(II) pool. One protein identified,Mzm1, was
found to be important for both the maintenance of matrix zinc
and assembly/stability of the respiratory Complex III. These
studies establish a link between Complex III andmitochondrial
zinc pools.
MATERIALS ANDMETHODS
Yeast Strains and Media—BY4741 and BY4743 strains
deleted for mzm1, cit1, mis1, mdh1, msb1, nfu1, and
tbs1 were purchased from Invitrogen and verified with open-
reading frame (ORF)3-specific PCR primers. Disruption of
MZM1 in the W303 background was accomplished by substi-
tuting the Candida albicans URA3 coding sequence. A 13Myc
epitope was fused to the 3 of the chromosomal-encoded
MZM1 ORF (Mzm1-Myc) in the W303 background. EDTA
supplementation (1 mM final concentration) to liquid synthetic
completemediumwas used to limit Zn availability forwild-type
cells. Lower levels of EDTA were used with mutant strains
when necessary. Strains were subsequently grown by serial
dilutions on plates with EDTA supplementation adjusted as
needed between 50 and 300 M. For large scale m-Adh1 limi-
tation of mitochondrial zinc, cells were grown in glassware
washed with acid (5% nitric acid, 1% HCl) using culture
mediummadewith yeast nitrogen base lacking Zn salts. For the
EDTA-based robotic screen, 0.2–0.5 mM EDTA supplementa-
tion was added to non-fermentable glycerol medium. Standard
synthetic complete medium was used in all other screens.
Expression Vectors—A pVT102-based Adh1::HA expression
clone (herein referred to as c-Adh1) utilizing theminimal, non-
zinc regulated ADH1 promoter was constructed by Dr.
Amanda Bird. To target c-Adh1 to the mitochondrial matrix,
the targeting sequence from Sod2 was fused to the ADH1ORF
using mega-primer PCR and gap-repair, herein referred to as
m-Adh1. Similarly the catalytically inactive m-Adh1 was gen-
erated by an alanine substitution of a critical threonine at posi-
tion 48 (15) by overlap extension PCR.
Robotic Screen—A collection consisting of deletion strains of
684 nuclear-encoded genes whose products were identified in a
survey of the yeast mitochondrial proteome was arrayed in a
96-well format. Growth was tested using robotically applied
serial dilutions of the strains on non-fermentable medium sup-
plemented with 0.4 mM EDTA. Similarly, the strain collection
was transformed with m-Adh1 (T48A) and screened for candi-
dates showing m-Adh1-dependent growth inhibition on non-
fermentable medium.
Preparation of Mitochondria—Mitochondria were isolated
as described previously (16). Briefly, lyticase was used to create
spheroplasts that were subsequently ruptured by vortexing
with glass beads or Dounce homogenizing for protein localiza-
tion experiments. Intact mitochondria were purified from the
cellular lysate using differential centrifugation and a discontin-
uousNycodenz gradient (14 and 22%).Mitochondria were then
centrifuged at 12,000  g to concentrate before analysis. Pro-
tein concentrations were determined using standard Bradford
protein reagents.
Mitochondrial Fractionation—To isolate submitochondrial
fractions, the outermembranewas lysed in 10mMTris-HCl, pH
7.4 (or 20 mM HEPES, pH 7.2 for protein localization experi-
ments), and the lysate subsequently centrifuged at 25,000 g to
separate the soluble IMS contents from mitoplasts retaining
matrix contents in the pellet fraction. To isolate soluble matrix
contents, mitoplasts were sonicated and again centrifuged at
25,000 g to separate soluble matrix contents from the mem-
brane fraction in the pellet. For batch-binding experiments,
either hydrated carboxymethyl cellulose 52 (CM-52) or
DEAE-52 ion exchange resins (Whatman) were added to solu-
ble mitochondrial lysate at 4 °C with elution in 1 M ammonium
acetate, pH 7.4, when needed. For fractionation of mitochon-
drial Zn, wholemitochondria were lysed by sonication in buffer
A (20mM ammonium acetate pH 7.4) using three 30-s pulses of
sonication at 70%output of amicrotip. The soluble fractionwas
then isolated by centrifugation at 15,000 g. The soluble frac-
tionwas further diluted into bufferA, filtered through a 0.45M
filter and injected onto either pre-equilibrated HR5/5 MonoQ
or MonoS columns. The unbound fractions were washed off
with 5 column volumes of buffer A. A 25–35 column-volume
gradient of buffer B (1 M ammonium acetate, pH 7.4) was then
initiated. Treatments of mitochondrial Zn samples, or free zinc
controls were as follows: soluble mitochondrial lysate was
boiled for 5 min and clarified by centrifugation 15,000  g
prior to injection; for citrate competition experiments, a
10-fold excess of citrate was mixed with either a MonoS-
prepurified Zn-ligand sample or buffered free Zn and imme-
diately injected onto MonoS and fractionated as above. For
size exclusion chromatography, concentrated cationic frac-
tions were injected on a Sephadex G-25 column pre-equili-
brated in 2 phosphate-buffered saline. Fractions were col-
lected and analyzed either by atomic absorption or inductively
coupled plasma (ICP) spectroscopy.
Western Blot and Blue Native (BN) PAGE Analysis—For
Western blot analysis, 20–50 g of total protein from mito-
chondria was separated on a 12% SDS-PAGE gel system and
transferred onto nitrocellulose membranes for analysis. Mem-
branes were blocked prior to detection using 10% nonfat dry
milk in 1 PBS (50 mM Na2PO4, 100 mM NaCl2), and 0.01%
Tween 20. BN-PAGE was done essentially as described previ-
ously (17)with either 1%digitonin or 1%dodecylmaltoside used
to solubilize samples. Blots were reprobed after stripping in 3–5
washes of 25 mM glycine pH 2.0, 100 mM NaCl2, and 0.5%
Tween 20. Antibodies to porin (Por1), hemagglutinin (HA),
phosphoglycerate kinase 1 (Pgk1) were obtained fromMolecu-
lar Probes. Cox1, Cox2, and Cox3 antibodies were purchased
fromMitosciences. Antisera tomitochondrial aconitase (Aco1)
3 The abbreviations used are: ORF, open-reading frame; ICP, inductively cou-
pled plasma; BN, blue native; HA, hemagglutinin; WT, wild type.
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was a gift from Dr. J. Kaplan. Antisera to the Rieske iron sulfur
protein (Rip1) was a gift from Dr. B. Trumpower. Antisera to
cytochrome 1 (Cyt1) was a gift fromDr. B.Meunier. Antisera to
cytochrome b2 was provided by Dr. C. Koehler. Anitsera to the
F1 ATPase beta subunit (Atp2) and core protein 2 (Cor2) were
provided by Dr. A. Tzagoloff.
Metal Analysis—For ICP-OES mitochondria, were resus-
pended in 200 l of metal-free 40% nitric acid (Optima) and
heated to 95 °C for 2 min. Soluble fractions were read directly
after dilutionwith 10%nitric acid. Volumetric serial dilutions of
commercially available mixed metal standards were used to
generate standard curves. For Atomic Absorption Spectros-
copy, soluble fractionswere comparedwith suitable blank read-
ings and concentrations calculated from ICP-verified stan-
dards. The Zn-dependent fluorophore, RhodZin-3 dipotassium
salt (Molecular Probes) was used to assess labile zinc concen-
trations. Either submitochondrial fractions, or soluble mito-
chondrial contents from 20–100g of total mitochondria son-
icated in cold 10 mM Tris, pH 7.4, were analyzed in triplicate.
Samples were diluted 1:5 in cold 30–60 M RhodZin-3, 10 mM
Tris, pH 7.4, and allowed to incubate for 30 s prior tomeasuring
maximal emission at 575 nm (excitation at 535 nm) on a Perkin
Elmer SS55 fluorimeter.
Measurement of Mitochondrial Respiration—Oxygen con-
sumption by cells grown to stationary phase and then diluted to
an A600 of 0.5 in 3 ml of 5% glycerol was determined using a
5300A biological oxygen monitor (Yellow Springs Instrument
Co.). Activities of the respiratory complexes were measured as
previously reported using 10–20 g of mitochondria in 40 mM
KH2PO4 pH 6.7, 0.5% Tween 20 with 32 M horse cytochrome
c (18). Cytochrome c was chemically reduced using sodium
hydrosulfite for Complex IV activities; to measure the coupled
Complex II/III activity cytochrome c reduction was monitored
upon succinate addition in the presence of KCN to inhibit
Complex IV. For Complex III measurements, the reduction of
bovine cytochrome c was measured using the same buffer sys-
tem and KCN inhibition as above. Complex III was directly
reduced by 20 M of the reduced ubiquinone analog, decylu-
biquinone (Sigma). Reduced decylubiquinone was prepared
anaerobically using saturated sodium borohydride. Excess
borohydride was later reacted with 6 N HCl while venting to
allow release of hydrogen gas. Any precipitates in the reduced
decylubiquinone were spun down and the solution transferred
to a fresh vial under nitrogen. The decylubiquinone concentra-
tion was determined on a pre-reduced aliquot using the molar
extinction coefficient () of 12.5 mM1 cm1 at 275 nM.
RESULTS
Distribution of ZnwithinMitochondria—The zinc content of
gradient-purified mitochondria was assessed in cells cultured
in YPD (1% dextrose) medium in the presence and absence of
supplemental ZnCl2. The Zn content was found to be main-
tained at a nearly constant value until supplemental zinc levels
exceeded 200 M, at which point an expansion in mitochon-
drial zinc content was observed (Fig. 1A). To assess the distri-
bution of zinc within mitochondria, purified and sonicated
mitochondria were fractionated into soluble and particulate
(pellet) fractions and subjected to ICP-OES analysis. As can be
seen in Fig. 1B, Zn(II) was equally distributed between these
fractions in mitochondria from cells cultured in unsupple-
mented YPD medium. Mitochondria from cells supplemented
with 200M Zn(II) contain a 3-fold expansion of total zinc that
was also equally distributed between soluble and particulate
fractions. The soluble fractions from Zn-supplemented and
unsupplemented cells were further fractionated by adsorption
to DEAE- or CM-cellulose to isolate their cationic and anionic
components, respectively. Zn(II) was similarly distributed
between cationic and anionic pools inmitochondria from zinc-
supplemented and unsupplemented cells. Cationic and anionic
Zn(II) fractions obtained from unsupplemented cultures were
incubated with the Zn-responsive RhodZin-3 fluorophore (Fig.
1C). The fluorescence of the cationic Zn fraction significantly
exceeded that of the anionicZn fraction despite having a similar
zinc concentration suggesting that the cationic Zn fraction pos-
sessed greater kinetic reactivity.
The soluble mitochondrial lysates isolated from control and
Zn-supplemented cells were adsorbed to MonoS and MonoQ
ion exchange resins to further fractionate the cationic and an-
ionic pools, respectively (Fig. 1, D and F). MonoS and MonoQ
columns were eluted with a gradient of ammonium acetate. A
major Zn-containing fraction was observed in the eluate of
each exchanger, and the abundance of each component was
increased in mitochondria isolated from Zn-supplemented
cells. To assess the nature of the Zn component in the eluate of
each exchanger, themitochondrial lysate isolated fromZn-sup-
plemented cells was first pretreated by boiling prior to the chro-
matography.Whereas the Zn component in theMonoQ eluate
was depleted by boiling, the Zn component in the MonoS
eluate was largely stable (Fig. 1, D and F). The MonoS Zn
component was also resistant to proteinase K digestion sug-
gesting that the MonoS Zn component is not protein bound
(data not shown). To determine whether this cationic Zn com-
ponent represents unboundZn(II), both ZnCl2 and the purified
cationic Zn complex were incubated with citrate prior to
MonoS chromatography. As shown in Fig. 1E, the elution posi-
tion of the cationic Zn component was unchanged, whereas
no Zn(II) was seen in the eluate during chromatography of a
preformed Zn-citrate complex. The cationic Zn complex
eluted from Sephadex G-25 near the internal volume con-
sistent with a low mass Zn(II) complex (Fig. 1G). These data
indicate that the cationic pool of labile zinc in the mitochon-
drial matrix is largely complexed with one or more com-
pounds of low molecular mass. We will refer to this labile zinc
pool as the cationic zinc pool because it adsorbs on cation
exchangers and appears to be a monodisperse component.
Effect of a Heterologous Zn Competitor on Mitochondrial Zn
Distribution—We previously demonstrated that the bioavailable
Cu(I) pool in yeast mitochondria was titrated out by the presence
of heterologous Cu(I)-binding proteins targeted to themitochon-
drial matrix (19, 20). To determine whether a similar situation
existed with the mitochondrial Zn fractions, we fused the Sod2
mitochondrial targeting sequence (MTS) to the cytoplasmicAdh1
molecule, designated m-Adh1, resulting in mitochondrial local-
ization (Fig. 2A). Two m-Adh1 constructs were engineered. One
fusionwas theWTAdh1sequence,whereas the second fusionwas
a catalytically inactive Adh1 allele (T48A). Yeast containing the
Mzm1 andMitochondrial Zinc Homeostasis
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m-Adh1 fusions as well as a control Adh1 construct lacking the
MTS (c-Adh1) were plated on Zn-limiting growth medium con-
tainingeitherglucoseorglycerol inorder toassess theeffectsof the
matrix targeted Adh1 (Fig. 2B). Cells harboring m-Adh1 and
m-Adh1 (T48A) showed a growth impairment on glycerol/lactate
medium and growth on this medium was enhanced by the inclu-
sionof supplemental Zn(II) suggesting that the respiratory growth
impairment was a Zn effect. To confirm the Zn effect, zrt1 cells
lacking the high affinity Zn(II) permease Zrt1 were transformed
with plasmids encoding either c-Adh1 or m-Adh1. The presence
of m-Adh1 in zrt1 cells compromised respiratory growth with-
out requiring zinc-limiting culture medium (Fig. 2C).
Mitochondria were purified from
yeast transformants to assess mito-
chondrial zinc levels. Mitochondria
isolated from m-Adh1 cells cultured
in standard complete medium ex-
hibited a marked increase in mito-
chondrial Zn (Fig. 2D) and chroma-
tography of soluble lysates onMonoS
revealedacomparable level of thecat-
ionic Zn component in the elution
gradient, whereas elevated Zn(II) was
detected in the column wash frac-
tions. Treatment of the soluble lysate
with RhodZin-3 revealed no change
in fluorescence in lysates isolated
from c-Adh1 mitochondria versus
m-Adh1 mitochondria (Fig. 2D, right
panel).Thus, thepresenceofm-Adh1
in the mitochondria of cells propa-
gated on synthetic complete growth
medium leads to an expansion of the
mitochondrial zinc content to
accommodate the high Adh1 levels.
This is further evidence of homeo-
static control of the mitochondrial
zinc pool.
In contrast to the marked expan-
sion of mitochondrial Zn seen in
mitochondria isolated from m-Adh1
transformants cultured in standard
growth medium, the use of Zn-lim-
iting conditions (synthetic culture
medium prepared from Zn-defi-
cient nitrogen base) yielded mito-
chondria with a slight diminution
in total mitochondrial Zn from
m-Adh1-containing cells (Fig. 2E).
MonoS chromatography of soluble
lysates from these mitochondria
revealed a decrease in the cationic
Zn component and corresponding
increase in the Zn content of the
unabsorbed wash fractions that
contained Adh1 immunoreactivity
(data not shown). Mitochondrial
lysates from either c-Adh1 or
m-Adh1 cellswere incubatedwithRhodZin-3 under conditions
of equal total mitochondrial protein levels, and the lysates from
m-Adh1 mitochondria showed a dramatic attenuation in
RhodZin-3 reactivity. Thus, the presence of m-Adh1 led to a
marked shift of the RhodZin-3 reactive cationic Zn pool to Zn
associated with m-Adh1. These conditions correlate with the
respiratory growth defect observed in Fig. 2B.
High-throughput Screen of Yeast Deletion Strains for Attenu-
ation in Labile Mitochondrial Zn—To identify proteins impor-
tant for maintenance of the labile zinc pool, we conducted two
high-throughput screens of yeast deletion mutants affecting
genes of knownor predictedmitochondrial proteins.Of the 851
FIGURE1.Mitochondrial zincpools.Yeast culturesweregrown in yeast peptone1%dextrose (YP1D)medium
and supplemented with 0–200 M ZnCl2. Mitochondria were isolated from cultures in triplicate and analyzed
for zinc either fromtotal or submitochondrial fractionsby ICP-OES.Panel A, titrationof supplemental zinc to cell
cultures results in expansion of mitochondrial zinc. Panel B, soluble and pellet fractions were isolated from 0.5
mg of mitochondria by sonication and centrifugation. Ion exchange using either CM-52 or DEAE-52 cellulose
was used to separate cationic and anionic fractions respectively. Panel C, using the Zn-dependent fluorophore
Rhodzin-3, reactive zinc was assessed in mitochondrial lysate from 0.1 mg of mitochondria depleted of either
anionic or cationic Zn pools (post DEAE-52 or CM-52 binding, respectively; n  4). Panels D–F, MonoS and
MonoQ ion exchange chromatography. Mitochondria were isolated from YP1D yeast cultures grown with 0.2
mM Zn (Zn) or without (Zn, Endogenous) and samples (equivalent to 0.5 mg of protein) were sonicated,
clarified, and boiled where indicated. Panel D, fractionation of soluble lysate using MonoS shows a single
cationic zinc peak that expands in response to zinc supplementation and is resistant to boiling. Panel E, either
freeZn(II) in the formofZnCl2orpreviouslypurifiedmitochondrial cationicZnweremixedwitha10-foldexcess
of citrate and examined for the ability to bind toMonoS cation exchange resin. Panel F, fractionation of soluble
lysate using MonoQ anion exchange reveals a broad peak that expands modestly in response to zinc supple-
mentation, yet is not resistant to boiling. Panel G, gel filtration of the cationic zinc fraction isolated by MonoS
elutes on a G25 size exclusion column in a volume corresponding to salt. 280 nm absorbance for both bovine
serumalbumin (BSA) andVitaminB12 (B12) are shown. Volumeexclusion (VE) and volume total (VT) aremarked.
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total proteins in themitochondrial proteome identified to date,
684 are not essential for growth. These 684 viable mutant
strains were arrayed in 96-well microtiter plates amenable to
robotic manipulations.
Initially, serial dilutions of the strainswere performed roboti-
cally and the cells were plated on Zn-limited culture medium
(YP glycerol/lactate containing 0.4 mM EDTA). Ten deletion
strains initially exhibited partial growth impairment onZn-lim-
ited glycerol/lactate medium. Of these, only one strain
(YDR493W renamed mzm1, Mzm1 designating mitochon-
drial zinc maintenance) exhibited highly reproducible Zn-
sensitive respiratory growth. The mzm1 strain exhibited a
growth defect on glycerol/lactatemediumwhenZn(II) was lim-
iting, and this phenotype was sup-
pressed by zinc supplements. In addi-
tion, themzm1mutant grew poorly
at 37 °C in the absence of Zn limita-
tion. These effects were largely sup-
pressed by introduction of the
MZM1 gene on a plasmid (Fig. 3A).
However, growth of the mutant on
glycerol/lactate medium at 37 °C
was only partially restored by the
addition of supplemental zinc salts
indicating that exogenous zinc does
not completely restore the cell to a
normal state. Cells lacking Mzm1
also grew poorly when transformed
with an episomal vector expressing
m-Adh1 and cultured on glycerol/
lactate medium (Fig. 3B). The
growth impairment was observed
only in cells containingm-Adh1 and
not c-Adh1. Thus,mzm1mutants
grow poorly on respiratory carbon
sources when zinc is limiting and
this effect is reproduced by mito-
chondrial zinc depletion caused by
m-Adh1 expression.
The second high throughput
screen involved transforming the
684 deletion strains with a vector
encoding the catalytically inactive
T48A m-Adh1. Transformants were
serially diluted and plated on glu-
cose and glycerol/lactate culture
medium. Thirty-five strains exhibit-
ing a defect on glycerol/lactate only
in the presence of m-Adh1 (T48A)
were collected for subsequent anal-
ysis. Transformation was repeated
with the 35 candidate deletion
strains using both m-Adh1 and
c-Adh1, and transformants were
plated on medium in the presence
and absence of supplemental zinc.
In addition to mzm1 cells, we
identified six other mutant strains
that exhibited a reproducible growth impairment on glycerol/
lactatemedium in the presence ofm-Adh1 but not c-Adh1 (Fig.
4A). These included cit1,mdh1,mis1,msb1, nfu1, and
tbs1 cells. Limited rescue of the growth defect of certain trans-
formants was achieved by supplemental zinc. Mitochondria
purified from the six deletion strains were used for quantitation
of total mitochondrial zinc by ICP-OES analysis and labile zinc
by RhodZin-3 reactivity. Mitochondrial zinc was depressed in
the cit1,mdh1, and tbs1 cells andRhodZin-3 reactivity was
also attenuated in these strains with an especially marked
reduction inmdh1 cells (Fig. 4B). Cit1 andMdh1 are the citric
acid cycle enzymes citrate synthase andmalate dehydrogenase,
whereas Tbs1 is a large 1095-residue mitochondrial protein of
FIGURE 2. Effect of matrix-targeted Adh1 (m-Adh1) on mitochondrial zinc. Upper panel A, a schematic
depicting the N-terminal fusion of the Sod2 mitochondrial targeting sequence directing Adh1 to the matrix,
where upon import the Sod2 presequence is removed. Lower panel A, relative expression of c-Adh1 and
m-Adh1 in both whole cell extracts and gradient-purified mitochondria relative to the respective loading
controls Pgk1 and Por1. Panel B, wild-type yeast expressing either m-Adh1, or a catalytic inactive m-Adh1
mutant (T48A), show respiratory phenotypes when grown under Zn-limited conditions that are suppressed in
thepresenceof excessZn.Panel C, yeast lacking theplasmamembranezinc transporter, Zrt1, showanm-Adh1-
induced respiratory phenotype without EDTA supplementation. Left panel D, total mitochondrial zinc from
both c-Adh1- and m-Adh1-expressing cells obtained from cultures grown in synthetic complete Zn-replete
medium. Right panel D, MonoS fractionation and Rhodzin-3 fluorescence (n  3) of soluble mitochondrial
lysates from either c-Adh1- or m-Adh1-expressing cultures. Left panel E, total mitochondrial zinc from both
c-Adh1- and m-Adh1-expressing cells obtained from cultures grown in synthetic complete Zn-deficient
medium. Right panel E, MonoS fractionation and Rhodzin-3 fluorescence (n  3) of soluble mitochondrial
lysates Zn-deficient cultures.
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unknown function. The marked respiratory defect of mzm1
mutants in zinc-limited medium and that it was an un-anno-
tated ORF led us to focus our subsequent studies on the char-
acterization of Mzm1.
Mzm1 Is Localized within theMitochondrialMatrix—Mzm1
is a 13.9-kDa mitochondrial protein (21). The chromosomal
MZM1 was epitope tagged with Myc to generate a C-terminal
Myc-tagged protein. The tagged protein is functional and
retained inmitoplasts and was resistant to proteinase K in both
intact mitochondria and mitoplasts (Fig. 5A). The Mzm1 pro-
tein was released by sonication of mitochondria suggesting it is
a soluble matrix protein (Fig. 5B). The exclusive mitochondrial
localization of Mzm1 was recently shown by an alpha comple-
mentation test (22). Mzm1 is not part of a large protein com-
plex; the protein fractionates as a lower mass protein during
sucrose gradient centrifugation (Fig. 5C).
Mitochondrial Phenotypes of mzm1 Cells—The growth
phenotypes of mzm1 mutants suggest that zinc homeostasis
in mitochondria is disrupted. Consistent with this hypothesis,
mitochondria purified from mzm1 cells have decreased Zn
contentwith no significant changes in iron, copper,manganese,
ormagnesium levels (Fig. 6A, data not shown). Themutant cells
also show amarked decrease in RhodZin-3 reactivity consistent
with a diminished cationic Zn component (Fig. 6B). This was
corroborated by fractionation of mitochondrial lysates from
WT versus mzm1 cells by ion exchange chromatography. The
anionic Zn fractionwas not perturbed inmzm1 cells (Fig. 6D),
but the cationic Zn fraction was greatly reduced (Fig. 6E).
As mentioned, mzm1 cells are impaired for respiratory
growth at 37 °C and at 30 °C upon zinc limitation. To assess the
respiratory capacity of the mutant cells, oxygen consumption
was measured in WT and mutant cells (Fig. 7A). Total oxygen
consumption was reduced in themutant cells at both 30 °C and
37 °C. Activities of Complexes III and IV were assessed in both
W303 and BY4741 genetic back-
grounds and the mzm1 cells were
found to have amarked reduction in
the activity of Complex III (bc1)
measured either as succinate cyto-
chrome c reductase activity or
ubiquinol cytochrome c reductase
activity (Fig. 7B). Complex IV (cyto-
chrome c oxidase) activity was unaf-
fected in themzm1 strain.
Impaired bc1 Complex Activity
Was Corroborated by Analysis of
the Respiratory Complexes—Dode-
cyl maltoside solubilization reduces
supercomplexes to individual com-
plexes that can be separated by BN-
PAGE. Visualization of the bc1 com-
plex using antibodies to three
separate subunits revealed its atten-
uation in mzm1 cells (Fig. 8A,
lanes 2, 4, 6). Despite disruption of
the assembled bc1 complex, the
steady-state levels of bc1 subunits
Cyt1 and Cor2 were not changed
(Fig. 8B). However, a partial decrease in steady-state levels of
Rip1 was seen inmzm1 cells. Although the bc1 complex abun-
dance was diminished, no change was observed in either cyto-
chrome c oxidase or ATP synthase complexes (Fig. 8A, lanes 8
and 10, respectively). As expected from the decrease in the bc1
complex, the abundance of bc1/cytochrome c oxidase super-
complexes was significantly reduced in mzm1 cells as
observed with digitonin solubilization (Fig. 8C, lanes 2 and 4).
No changes were evident in the monomeric and dimeric ATP
synthase complexes (Complex V) (Fig. 8C, lanes 5 and 6).
Because mzm1 cells show decreased matrix Zn(II), we tested
whether zinc supplements would restore bc1 activity. Mutant
cells cultured in 200MZn(II) failed to restore bc1 activity (data
not shown).
DISCUSSION
We demonstrate for the first time that a bioavailable pool of
Zn(II) exists within themitochondrialmatrix that appears to be
critical for mitochondrial function. This pool can be titrated
out by expressing a matrix-targeted Zn-binding protein,
m-Adh1, in cells propagated in Zn-limitingmedium. The labile
Zn(II) pool is ligand-bound and is cationic in nature. It is stable
in the presence of citrate as a competitor but is reactive with the
Zn-responsive fluorophore RhodZin-3. The matrix bioavail-
able Zn(II) pool increases in cells cultured with supplemental
Zn(II) salts in excess of 200 M. Current studies are underway
to structurally characterize this cationic Zn component.
The physiological significance of the matrix Zn(II) pool may
relate to either a detoxification mechanism for the metal or a
Zn(II) reservoir for metallation of Zn-binding proteins within
the matrix. Previous work demonstrated that the yeast vacuole
is the major reservoir of excess Zn(II) accumulated in cells cul-
tured in high zinc (23–25). A marked expansion of the mito-
chondrial matrix zinc pool does not occur when the medium
FIGURE 3. Zn-dependent respiratory defects. In a large-scale screen for mutants showing Zn-dependent
respiratory defects, we isolatedmzm1 from a collection of 684 deletion strains lacking proteins predicted to
havemitochondrial localization. Panel A,mzm1 cells are unable to grow on respiratory carbon sources under
Zn-limited conditions (EDTA) or at elevated temperature relative to both wild type and the complemented
strain. Panel B, the presence of m-Adh1 severely restrictsmzm1 respiratory growth.
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zinc concentration is below 200 M. Detoxification of zinc
within the vacuole is efficient and mutations that disrupt vacu-
olar zinc storage render cells very sensitive to zinc toxicity.
Thus, themitochondrial zinc pool is not likely to be a significant
mechanism of zinc detoxification.
The matrix Zn(II) pool appears important in mitochondrial
zinc metallation reactions. The plethora of Znmetalloenzymes
within mitochondria implies that a significant bioavailable
Zn(II) pool must exist for the metallation of these molecules
upon their import. In support of this postulate is the observa-
tion that attenuation in the labile pool by the matrix-targeted
m-Adh1 correlates with impaired oxidative phosphorylation
and respiratory growth. The dominant negative effects of
m-Adh1 do not arise from perturbation in metabolism within
the matrix due to the catalytic activity of Adh1, because the
same effects are observed with a catalytically inactive matrix
Adh1. This suggests that Zn(II)-chelation is the likely cause of
the respiration defect. This is corroborated by two observa-
tions. First, the respiratory growth of cells harboring m-Adh1
are partially rescued in by supplemental zinc in the growth
medium, and second that m-Adh1 provokes respiratory defi-
ciency in cells lacking the zinc importer, Zrt1. The dominant
negative effects ofm-Adh1 are not observed in cells propagated
on zinc-sufficient standard culture medium. Under these cul-
ture conditions the presence ofm-Adh1 results in an expansion
of mitochondrial Zn(II) corresponding to formation of
Zn-Adh1 and likely represents homeostatic regulation of the
labile zinc pool.
Metal ion transporters in the mitochondrial IM have been
identified for only Fe(II) ions. Transporters that mediate mito-
chondrial import of Zn(II), Mn(II), and Cu(I)/Cu(II) have not
been defined. In an attempt to identify proteins important for
mitochondrial import of Zn(II) or maintenance of the labile
Zn(II) pool, we conducted two different high throughput
screens.With a collection of yeast deletion strains ofmitochon-
drial proteins, we screened for respiratory growth defects on
Zn-limiting medium and identifiedmzm1 cells as sensitive to
Zn limitation.
Mzm1 is a mitochondrial matrix protein that not only influ-
ences the matrix cationic Zn pool but also has a role in the
assembly or stability of the bc1 complex. Cells lacking Mzm1
exhibited respiratory growth sensitivity to both Zn-limited
FIGURE 4.m-Adh1-induced respiratory deficiency. Panel A, yeast mzm1,
cit1, mdh1, mis1, msb1, nfu1, and tbs1 strains were identified as
m-Adh1 (T48A) sensitive from the collection of 684 strains lacking predicted
mitochondrial proteins. Strains were re-transformed with either c-Adh1 or
m-Adh1 (T48A) and grown in either synthetic complete (SC) glucosemedium
without (Zn) or with (Zn) 500M supplemental ZnCl2. Cultures were then
serially diluted onto SC medium agar with glucose or glycerol as carbon
sources. All strains were verified by PCR using a universal KanMX and gene-
specific primers. Panel B, mitochondria from cit1, mdh1, mis1, msb1,
nfu1, and tbs1 cells were purified from cells grown in standard SC 1%
glucose medium for comparison to wild-type mitochondria. Both total mito-
chondrial zinc and reactive zinc, as assessed with Rhodzin-3, were measured
in triplicate on three independent mitochondrial preparations.
FIGURE 5. Localization ofMzm1. Panel A, mitochondria (100g) expressing
Mzm1-Mycwere kept intact ( swell, lanes 1 and 2) or swollen ( swell, lanes
3 and 4) and incubatedwith (lanes 2 and 4) or without (lanes 1 and 3) protein-
ase K (PK). The matrix marker protein is Aco1, mitochondrial aconitase; inner
mitochondrial space protein is Cyb2, cytochrome b2. Panel B, mitochondria
(100 g of protein) were fractionated using both hypotonic lysis (swelling)
and sonication. Pellet (P) and soluble (S) fractions were isolated by centrifu-
gation (see “Materials and Methods” for details). In swollen mitoplasts in the
absence of sonication, Mzm1 and Aco1 are retained in the pellet fraction.
Detection with porin (Por1) antibodymarks the pellet fraction. Panel C, mito-
chondria (1 mg) were solubilized in buffer containing 1% digitonin and cen-
trifuged over a continuous 7–30% sucrose gradient. Mzm1-Myc migration is
shown relative to Por1 andmarkers for Complex III (Rip1), and for Complex IV
(Cox2).
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medium and the presence of m-Adh1. The matrix cationic
Zn(II) component was attenuated in mzm1 cells in both
W303 and BY4741 backgrounds as seen byMonoS chromatog-
raphy and RhodZin-3 reactivity. In addition,mzm1 cells have
decreased accumulation of the dimeric bc1 complex. Reintro-
duction of the MZM1 gene into the mutant cells suppressed
both the mitochondrial zinc defect and the Complex III defi-
ciency suggesting a link between the
two phenotypes. However, supple-
mental zinc did not restore bc1 com-
plex activity in the mutant cells.
This is consistent with the failure of
supplemental zinc to fully restore
glycerol growth of the mutant at
37 °C. Thus, Mzm1 may have other
roles andmay affect zinc homeosta-
sis indirectly.
The nature of the link between
zinc and the bc1 complex is not
obvious as none of the bc1 complex
subunits have known Zn-binding
proteins. However, the matrix-fac-
ing Cor1 and Cor2 bc1 subunits are
homologous to the MPP zinc-met-
alloproteinase (26, 27). MPP is a
dimeric proteinase with an HxxEH
Zn motif in one subunit. The core
complex in the potato bc1 complex
functions as the generalMPP in that
species (28). However, vertebrate
bc1 core subunits have an altered
motif with a tyrosine replacing one
His residue (26). The yeast Cor1 and
Cor2 bc1 complex subunits lack the HXXEH motif, so it is
unlikely that a MPP-like function is conserved. A second link
between zinc and the bc1 complex is that the respiratory com-
plex is inhibited by Zn(II) and twoZn(II) binding sites permon-
omer weremapped in the avian complex (27). The two sites are
spatially close to ubiquinone binding site.
Two other scenarios are envisioned for the observed zinc/
bc1 relationship. First, Mzm1 may have two distinct roles in
the maintenance of the matrix Zn pools and assembly/stabil-
ity of the bc1 complex. Alternatively, the assembled bc1 com-
plex may have a role in mitochondrial Zn import or efflux
such that cells impaired in bc1 formation may be compro-
mised in mitochondrial zinc. A related link between a respi-
ratory complex and mitochondrial metal pools was observed
with coa1 and shy1 cells. Both mutants are impaired in
the biogenesis of cytochrome c oxidase and in the mainte-
nance of the matrix bioavailable Cu(I) pool (20, 29). Coa1
and Shy1 form complexes with newly synthesized Cox1 dur-
ing its maturation and we postulated that these assembly
intermediates may also modulate import of Cu(I) across the
IM. Whereas coa1 and shy1 cells are weakly suppressed
by supplemental copper in cultures, the respiratory defect of
mzm1 cells is not suppressed by supplemental zinc. Future
studies will focus on the role of Mzm1 in bc1 complex bio-
genesis as well as matrix zinc maintenance.
The second screen was with the same collection of mutant
strains transformed with a vector expressing matrix-targeted
m-Adh1. Seven deletion mutants were observed to exhibit a
respiratory growth deficiency in the presence of m-Adh1 but
not cytosolic c-Adh1. Although total mitochondrial zinc was
not markedly attenuated in most of these strains, RhodZin-3
reactivity of purified mitochondria was attenuated in several:
FIGURE 6. Mitochondrial Zn defect in mzm1 cells. Mitochondria were isolated for both WT and mzm1
from cells grown in yeast peptone 1% dextrose. Panel A, metal analysis of mitochondria (200g; n 3). Panel
B, mitochondria (50g) were sonicated in 0.1 ml 10mM Tris, and the clarified lysate incubated with Rhodzin-3
to asses Zn-dependent fluorescence. Following fluorescent measurements, lysates were analyzed for metal
content by ICP-OES (n  3). Panel C, MonoS fractionation of mzm1 soluble mitochondrial lysate. Panel D,
MonoQ fractionation ofmzm1 soluble mitochondrial lysate.
FIGURE 7. Respiratory defect in mzm1 cells. Panel A, total oxygen con-
sumption ofmzm1 relative to wild type at 30° and 37 °C. Panel B, analysis of
succinate cytochrome c reductase activity (Complex II/III), ubiquinol cyto-
chrome c reductase activity (Complex III), and cytochrome c oxidase activity
(Complex IV) using 10–20 g of mitochondria per reaction (see “Materials
and Methods” for details) (n 3 per assay).
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Mzm1, Cit1,Mdh1, Nfu1,Mis1,Msb1, and Tbs1 were all found
to contribute to the maintenance of the labile cationic Zn(II)
pool. Cit1 andMdh1 are citric acid cycle enzymes, so the deple-
tion of thesemoleculeswill alter the levels ofmatrixmetabolites
that may contribute to the cationic Zn(II)-component. Alter-
natively, Mdh1 was recently shown
to associate with submicromolar
affinity with the bc1 complex via the
matrix-facing Cor1 and Cor2 sub-
units (30). This interaction was
shown to stimulate the bc1 activity
and enhance the reverseMdh1 reac-
tion thereby consuming oxaloace-
tate. Cells lackingMdh1 were found
to be only modestly impaired in bc1
activity (83% of wild type), so the
link of Zn and bc1 assembly remains
unclear. Nfu1 is one of three matrix
scaffold proteins for the assembly of
Fe/S clusters. Mis1 is a mitochon-
drial candidate C1-tetrahydrofolate
synthase (31). One-carbon transfer
reactions are mediated by tetrahy-
drofolate and derivatives of THF are
required for the biosynthesis of
purines, thymidylate, pantothenate,
and certain amino acids. C1-tetra-
hydrofolate synthases mediate
interconversion of different oxida-
tion states of THF derivatives. Cells
lacking the cytosolic Ade3 C1-tetra-
hydrofolate synthase exhibit aux-
otrophies for adenine and histidine,
whereas cells lacking the mitochon-
drial Mis1 C1-tetrahydrofolate syn-
thase lack an obvious effect on ade-
nine or histidine biosynthesis or
respiration (31). Thus, Mis1 and
Ade3 have distinct functions and
the physiological significance of the
mitochondrial Mis1 remains
unclear. Although Msb1 is a mito-
chondrial protein, it is implicated in
glucan synthesis and the Pkc1-
MAPKpathway (32). No clearmito-
chondrial function is known for
Msb1. No function is ascribed for
Tbs1 either. None of these mole-
cules appear to be candidates for
membrane Zn(II) transporters. The
identity of the mitochondrial Zn(II)
transporter(s) remains unresolved.
No transporter-encoding genes
were identified in our screens sug-
gesting that mitochondrial zinc
transporters are either essential,
and thereforewould not be included
among the strains tested, or redun-
dantwith other genes such that loss of one does not greatly alter
mitochondrial zinc homeostasis.
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